Humana Inc.’s Stock Price Soars to $314.21, Notching an Impressive 4.01% Uptick

Humana Inc. (HUM)

314.21 USD +12.12 (+4.01%) Volume: 2.43M

Humana Inc.’s stock price has seen a promising uptick, trading at 314.21 USD, a positive change of +4.01% in the latest trading session. Despite a decrease of -31.37% YTD, the robust trading volume of 2.43M signifies investor interest. Stay updated on HUM’s stock price performance for smart investment decisions.

Latest developments on Humana Inc.

Despite a turbulent day of trading, Humana Inc. (NYSE:HUM) outperformed its competitors. The healthcare giant’s stock price movements were heavily influenced by a myriad of factors, including investors’ intense scrutiny and the company’s decision to withhold solid 2025 EPS guidance amidst looming uncertainties. Analysts have recently issued forecasts for Humana’s Q3 2024 earnings, contributing to the market’s anticipation. Moreover, financial contrasts with NeueHealth (NYSE:NEUE) and PGGM Investments’ $2.79 million position in the company have been noted. Significant price target adjustments have also been made, with figures ranging from $326.00 to $360.00.

Humana Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma have provided a bullish outlook on Humana Inc. in their recent research report titled “Humana Inc.: Launch of At-Home Primary Care Program & Other Developments”. The report highlighted that Humana exceeded revenue and earnings expectations, with adjusted earnings per share reaching $7.78. The company’s strong performance in Medicaid and primary care was noted, along with its strategic focus on Medicare Advantage for 2024, emphasizing consumer preferences and key benefits.

For more information on Humana Inc.’s analyst coverage and insights, you can visit Baptista Research‘s profile on Smartkarma. Stay tuned for more updates and analysis on Humana Inc.’s developments and performance in the healthcare sector.

A look at Humana Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. has been given a high score for its value, indicating a positive long-term outlook in terms of the company’s financial health and performance. With a strong focus on providing affordable and quality healthcare services to its members, Humana’s value score reflects its ability to generate sustainable returns for investors.

While Humana’s scores for dividend, growth, resilience, and momentum are not as high as its value score, they still indicate a stable and promising outlook for the company. With a diverse range of products and services offered to a wide range of customers, including employer groups, government-sponsored plans, and individuals, Humana is well-positioned to weather market fluctuations and continue to grow in the long run.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma